Subject
Clinical Trials; Drug Approval/*methods; Drug Labeling/standards; Drugs; Female; Generic/administration & dosage/*pharmacology; Humans; Male; Pharmaceutical Preparations/administration & dosage; Phase I as Topic; Phase II as Topic; Phase III as Topic; Sensitivity and Specificity; Therapeutic Equivalency; United States; United States Food and Drug Administration/*standards